No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3ne4A, 1.0000, 0.00, 1.000, 370, 370, 1.8 ANGSTROM STRUCTURE OF INTACT NATIVE WILD-TYPE ALPHA-1-ANTITRYPSIN
2, 1qlpA, 0.9970, 0.39, 1.000, 372, 370, 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS
3, 5nbuA, 0.9918, 0.37, 0.978, 370, 368, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
4, 3cwlA, 0.9917, 0.54, 1.000, 371, 369, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM B
5, 3cwmA, 0.9910, 0.57, 1.000, 369, 369, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE
6, 1oo8A, 0.9908, 0.71, 0.976, 370, 370, CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION
7, 2qugA, 0.9892, 0.55, 1.000, 368, 368, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM A
8, 1psiA, 0.9882, 0.78, 0.997, 371, 369, INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU
9, 5nbvA, 0.9788, 1.12, 0.976, 369, 368, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
10, 1ophA, 0.9753, 1.27, 0.962, 375, 369, NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
11, 3drmA, 0.9745, 0.44, 0.997, 362, 362, 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1- ANTITRYPSIN
12, 5io1A, 0.9707, 0.86, 0.989, 365, 364, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
13, 1hp7A, 0.9678, 1.47, 0.992, 376, 370, A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS
14, 5io1B, 0.9677, 0.87, 0.986, 364, 363, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
15, 3druA, 0.9416, 1.48, 0.986, 363, 362, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
16, 3druB, 0.9391, 1.44, 0.989, 362, 361, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
17, 3druC, 0.9383, 1.35, 0.989, 360, 359, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
18, 1kctA, 0.9340, 2.11, 0.959, 375, 367, ALPHA1-ANTITRYPSIN
19, 5hgcA, 0.9327, 1.84, 0.482, 373, 365, A SERPIN STRUCTURE
20, 3h5cA, 0.9323, 2.05, 0.334, 384, 368, X-RAY STRUCTURE OF PROTEIN Z-PROTEIN Z INHIBITOR COMPLEX
21, 4pywA, 0.9316, 1.57, 1.000, 362, 361, 1.92 ANGSTROM CRYSTAL STRUCTURE OF A1AT:TTAI TERNARY COMPLEX
22, 1atuA, 0.9315, 2.03, 0.949, 374, 369, UNCLEAVED ALPHA-1-ANTITRYPSIN
23, 4x30A, 0.9287, 1.97, 0.432, 372, 366, CRYSTAL STRUCTURE OF HUMAN THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROINE AT 1.55 ANGSTROM RESOLUTION
24, 3f1sA, 0.9265, 1.82, 0.331, 385, 363, CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
25, 2hijI, 0.9255, 2.35, 0.293, 411, 369, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
26, 1e04I, 0.9250, 2.40, 0.290, 403, 369, PLASMA BETA ANTITHROMBIN-III
27, 1e05I, 0.9238, 2.39, 0.295, 417, 369, PLASMA ALPHA ANTITHROMBIN-III
28, 2ceoA, 0.9235, 1.96, 0.440, 367, 361, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
29, 2antI, 0.9224, 2.41, 0.290, 419, 369, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
30, 2ceoB, 0.9222, 1.89, 0.442, 367, 360, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
31, 1dzhI, 0.9207, 2.47, 0.293, 417, 369, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
32, 1e03I, 0.9190, 2.48, 0.295, 418, 369, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
33, 1azxI, 0.9180, 2.48, 0.293, 417, 369, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
34, 1oyhI, 0.9176, 2.51, 0.293, 416, 369, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
35, 1antI, 0.9164, 2.39, 0.292, 402, 367, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
36, 4ga7A, 0.9163, 1.71, 0.289, 369, 356, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
37, 1dzgI, 0.9161, 2.48, 0.293, 422, 369, N135Q-S380C-ANTITHROMBIN-III
38, 1tb6I, 0.9159, 2.28, 0.298, 412, 366, 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX
39, 4ga7B, 0.9142, 1.60, 0.288, 367, 354, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
40, 2behI, 0.9142, 2.44, 0.292, 413, 367, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
41, 1athA, 0.9139, 2.44, 0.295, 389, 366, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
42, 4if8A, 0.9138, 1.82, 0.417, 367, 357, STRUCTURE OF VASPIN
43, 1ovaB, 0.9133, 2.10, 0.302, 371, 361, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
44, 1ovaD, 0.9131, 2.35, 0.297, 385, 364, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
45, 1uhgB, 0.9122, 2.33, 0.306, 380, 363, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
46, 1ovaA, 0.9121, 2.41, 0.305, 383, 364, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
47, 1uhgD, 0.9118, 2.32, 0.303, 380, 363, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
48, 4y3kA, 0.9114, 1.78, 0.420, 367, 355, STRUCTURE OF VASPIN MUTANT E379S
49, 3fgqB, 0.9110, 2.04, 0.285, 374, 361, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
50, 3fgqA, 0.9107, 2.05, 0.285, 374, 361, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
51, 4dy7F, 0.9099, 2.01, 0.242, 378, 360, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
52, 4y40A, 0.9097, 1.81, 0.420, 366, 355, STRUCTURE OF VASPIN MUTANT D305C V383C
53, 2h4rA, 0.9092, 1.88, 0.324, 371, 355, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE NATIVE CONFORMATION
54, 1nq9I, 0.9090, 2.44, 0.294, 406, 364, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
55, 2b4xI, 0.9089, 2.43, 0.293, 413, 365, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
56, 3kcgI, 0.9084, 2.24, 0.295, 419, 363, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA- PENTASACCHARIDE COMPLEX
57, 4dy7C, 0.9081, 2.04, 0.242, 377, 360, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
58, 1sr5A, 0.9078, 2.16, 0.301, 409, 362, ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE
59, 1t1fC, 0.9075, 2.01, 0.299, 419, 358, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
60, 1t1fB, 0.9075, 2.01, 0.299, 419, 358, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
61, 1t1fA, 0.9075, 2.01, 0.299, 419, 358, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
62, 4ajtA, 0.9073, 2.15, 0.339, 372, 360, THE CRYSTAL STRUCTURE OF MOUSE PROTEIN-Z DEPENDENT PROTEASE INHIBITOR(MZPI)
63, 2zv6B, 0.9067, 1.95, 0.336, 371, 354, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
64, 1jmjB, 0.9067, 2.32, 0.282, 387, 365, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
65, 2gd4I, 0.9058, 2.46, 0.301, 417, 366, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
66, 1uhgA, 0.9057, 2.39, 0.313, 378, 361, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
67, 5cdxA, 0.9056, 1.39, 0.608, 353, 347, CRYSTAL STRUCTURE OF CONSERPIN
68, 1yxaA, 0.9055, 2.30, 0.447, 372, 360, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
69, 2gd4C, 0.9052, 2.42, 0.301, 418, 365, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
70, 1br8I, 0.9048, 2.52, 0.292, 404, 367, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
71, 5ce0B, 0.9034, 1.43, 0.602, 353, 347, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
72, 1lk6I, 0.9031, 2.68, 0.293, 410, 369, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
73, 1jvqI, 0.9025, 2.69, 0.293, 410, 369, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
74, 3evjI, 0.9024, 2.46, 0.292, 404, 363, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
75, 1jmjA, 0.9023, 2.40, 0.282, 397, 365, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
76, 1r1lI, 0.9013, 2.71, 0.293, 416, 369, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
77, 1jmoA, 0.9011, 2.35, 0.280, 425, 364, CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX
78, 4dy0B, 0.9007, 1.98, 0.236, 370, 356, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
79, 1ovaC, 0.9001, 2.21, 0.303, 373, 356, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
80, 4c41A, 0.8996, 2.01, 0.445, 367, 355, CORTICOSTEROID-BINDING GLOBULIN WITH ENGINEERED DISULPHIDE BRIDGE BETWEEN RESIDUES 100 AND 236
81, 5ncsA, 0.8991, 2.25, 0.250, 374, 360, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
82, 1uhgC, 0.8989, 2.25, 0.306, 370, 356, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
83, 4if8B, 0.8985, 1.79, 0.414, 361, 350, STRUCTURE OF VASPIN
84, 5ce0A, 0.8984, 1.43, 0.612, 352, 345, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
85, 5ncsB, 0.8982, 2.26, 0.250, 374, 360, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
86, 4y40B, 0.8975, 1.75, 0.415, 361, 349, STRUCTURE OF VASPIN MUTANT D305C V383C
87, 4y3kB, 0.8963, 1.77, 0.415, 361, 349, STRUCTURE OF VASPIN MUTANT E379S
88, 1sekA, 0.8949, 2.51, 0.286, 376, 360, THE STRUCTURE OF ACTIVE SERPIN K FROM MANDUCA SEXTA AND A MODEL FOR SERPIN-PROTEASE COMPLEX FORMATION
89, 4c49A, 0.8948, 1.97, 0.446, 367, 354, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
90, 1yxaB, 0.8948, 2.22, 0.447, 368, 356, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
91, 2dutD, 0.8947, 2.24, 0.309, 366, 356, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
92, 2dutC, 0.8947, 2.24, 0.309, 366, 356, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
93, 2dutB, 0.8947, 2.24, 0.309, 366, 356, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
94, 2dutA, 0.8947, 2.24, 0.309, 366, 356, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
95, 1xqgB, 0.8940, 2.26, 0.256, 378, 360, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
96, 3pb1I, 0.8919, 2.51, 0.291, 375, 364, CRYSTAL STRUCTURE OF A MICHAELIS COMPLEX BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPE PLASMINOGEN ACTIVATOR
97, 1xqgA, 0.8918, 2.29, 0.258, 378, 360, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
98, 1xqjA, 0.8912, 2.30, 0.258, 378, 360, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP I 4 2 2
99, 2ol2A, 0.8909, 2.11, 0.467, 360, 353, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
100, 3f5nD, 0.8908, 2.12, 0.296, 363, 355, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
101, 3f5nA, 0.8908, 2.26, 0.295, 364, 356, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
102, 3vvjB, 0.8907, 2.28, 0.289, 384, 357, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
103, 3vvjC, 0.8905, 2.20, 0.289, 384, 356, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
104, 2vdxA, 0.8904, 2.00, 0.442, 366, 353, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
105, 3le2A, 0.8898, 2.36, 0.238, 393, 361, STRUCTURE OF ARABIDOPSIS ATSERPIN1. NATIVE STRESSED CONFORMATION
106, 1db2A, 0.8890, 2.65, 0.294, 377, 364, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
107, 3vvjA, 0.8886, 2.32, 0.289, 384, 357, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
108, 1attB, 0.8886, 2.24, 0.300, 410, 357, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
109, 6cj7A, 0.8878, 1.80, 0.282, 357, 348, CRYSTAL STRUCTURE OF MANDUCA SEXTA SERINE PROTEASE INHIBITOR (SERPIN)- 12 
110, 4c49B, 0.8878, 1.87, 0.450, 362, 349, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
111, 2b5tI, 0.8873, 2.41, 0.299, 415, 358, 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES
112, 3r4lA, 0.8870, 2.81, 0.293, 377, 365, HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1
113, 5du3A, 0.8867, 2.04, 0.267, 378, 352, ACTIVE FORM OF HUMAN C1-INHIBITOR
114, 3f5nB, 0.8866, 2.11, 0.295, 376, 353, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
115, 2hi9A, 0.8863, 2.32, 0.463, 356, 354, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
116, 5brrI, 0.8861, 2.70, 0.295, 372, 363, MICHAELIS COMPLEX OF TPA-S195A:PAI-1
117, 4c49C, 0.8855, 1.90, 0.447, 363, 349, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
118, 2vdxB, 0.8854, 1.80, 0.447, 360, 347, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
119, 4dteA, 0.8853, 2.57, 0.253, 374, 363, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
120, 2zv6A, 0.8851, 1.62, 0.341, 350, 343, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
121, 1attA, 0.8850, 2.16, 0.299, 420, 354, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
122, 5du3B, 0.8849, 2.10, 0.264, 377, 352, ACTIVE FORM OF HUMAN C1-INHIBITOR
123, 1k9oI, 0.8848, 2.75, 0.286, 376, 360, CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX
124, 1xu8B, 0.8837, 2.45, 0.251, 373, 358, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
125, 2zv6C, 0.8824, 1.62, 0.345, 350, 342, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
126, 2hi9B, 0.8824, 2.16, 0.462, 354, 351, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
127, 5ei0A, 0.8821, 2.13, 0.424, 372, 354, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
128, 4eb1I, 0.8821, 3.01, 0.290, 411, 366, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
129, 3b9fI, 0.8816, 2.09, 0.466, 356, 350, 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX
130, 1imvA, 0.8816, 2.22, 0.282, 375, 355, 2.85 A CRYSTAL STRUCTURE OF PEDF
131, 2vdyB, 0.8812, 1.98, 0.443, 361, 348, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
132, 4dteB, 0.8810, 2.29, 0.259, 364, 355, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
133, 5duqA, 0.8809, 2.09, 0.269, 362, 350, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
134, 1oc0A, 0.8809, 2.34, 0.301, 364, 355, PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN
135, 3q03A, 0.8806, 2.03, 0.298, 360, 349, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
136, 5ei0E, 0.8805, 2.10, 0.425, 371, 353, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
137, 3ozqA, 0.8804, 2.18, 0.282, 364, 351, CRYSTAL STRUCTURE OF SERPIN48 WHICH IS A HIGHLY SPECIFIC SERPIN IN THE INSECT TENEBRIO MOLITOR
138, 3pzfA, 0.8800, 2.47, 0.213, 369, 356, 1.75A RESOLUTION STRUCTURE OF SERPIN-2 FROM ANOPHELES GAMBIAE
139, 4dy0A, 0.8798, 2.04, 0.246, 362, 349, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
140, 5duqB, 0.8795, 2.12, 0.271, 365, 350, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
141, 2hi9C, 0.8771, 1.95, 0.475, 346, 345, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
142, 2vdyA, 0.8770, 2.05, 0.443, 361, 348, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
143, 3ut3C, 0.8766, 2.40, 0.299, 368, 354, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
144, 2r9yA, 0.8764, 1.97, 0.277, 365, 347, STRUCTURE OF ANTIPLASMIN
145, 1b3kC, 0.8762, 2.51, 0.301, 373, 356, PLASMINOGEN ACTIVATOR INHIBITOR-1
146, 1b3kA, 0.8761, 2.51, 0.301, 373, 356, PLASMINOGEN ACTIVATOR INHIBITOR-1
147, 1dvmA, 0.8755, 2.47, 0.299, 375, 355, ACTIVE FORM OF HUMAN PAI-1
148, 1dvmD, 0.8749, 2.42, 0.297, 372, 354, ACTIVE FORM OF HUMAN PAI-1
149, 1dvmB, 0.8749, 2.36, 0.299, 365, 354, ACTIVE FORM OF HUMAN PAI-1
150, 4roaA, 0.8746, 2.49, 0.215, 364, 354, 1.90A RESOLUTION STRUCTURE OF SRPN2 (S358W) FROM ANOPHELES GAMBIAE
151, 1xu8A, 0.8740, 2.21, 0.254, 365, 351, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
152, 1jtiA, 0.8740, 2.27, 0.299, 381, 351, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
153, 1jtiB, 0.8739, 2.27, 0.299, 381, 351, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
154, 2ol2B, 0.8735, 1.87, 0.478, 343, 343, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
155, 3ut3A, 0.8732, 2.42, 0.300, 367, 353, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
156, 3q02A, 0.8731, 2.15, 0.298, 358, 349, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
157, 1dvmC, 0.8724, 2.45, 0.291, 364, 354, ACTIVE FORM OF HUMAN PAI-1
158, 3f5nC, 0.8721, 2.42, 0.287, 358, 348, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
159, 1by7A, 0.8719, 1.90, 0.321, 354, 343, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT
160, 4zk0A, 0.8717, 2.15, 0.335, 367, 349, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. HIGH PH STRUCTURE
161, 4g8rB, 0.8716, 2.40, 0.298, 368, 352, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
162, 4g8oD, 0.8713, 2.41, 0.295, 367, 352, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
163, 4g8oC, 0.8708, 2.42, 0.301, 367, 352, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
164, 3ndaA, 0.8705, 2.33, 0.303, 374, 353, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
165, 3ndaB, 0.8702, 2.23, 0.305, 372, 351, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
166, 4zk3A, 0.8694, 2.16, 0.342, 366, 348, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. LOW PH STRUCTURE
167, 1db2B, 0.8694, 2.29, 0.303, 362, 350, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
168, 4ic0C, 0.8692, 2.44, 0.298, 366, 352, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
169, 4ic0A, 0.8690, 2.43, 0.293, 366, 352, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
170, 4c49D, 0.8688, 1.92, 0.443, 356, 343, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
171, 2peeA, 0.8687, 2.59, 0.242, 387, 355, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
172, 3ut3D, 0.8683, 2.30, 0.303, 360, 350, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
173, 2peeB, 0.8682, 2.73, 0.242, 387, 356, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
174, 3ut3B, 0.8680, 2.30, 0.303, 360, 350, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
175, 3q03B, 0.8678, 2.30, 0.294, 364, 350, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
176, 1b3kD, 0.8669, 2.29, 0.304, 358, 349, PLASMINOGEN ACTIVATOR INHIBITOR-1
177, 1b3kB, 0.8669, 2.29, 0.304, 358, 349, PLASMINOGEN ACTIVATOR INHIBITOR-1
178, 1wz9B, 0.8667, 2.25, 0.273, 355, 348, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
179, 4p0oA, 0.8650, 2.35, 0.309, 371, 350, CLEAVED SERPIN 42DA
180, 3q02B, 0.8650, 2.25, 0.296, 362, 348, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
181, 2arqA, 0.8643, 2.41, 0.311, 360, 351, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH
182, 4g8oA, 0.8635, 2.30, 0.296, 359, 348, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
183, 4g8oB, 0.8634, 2.30, 0.296, 359, 348, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
184, 4ic0D, 0.8633, 2.31, 0.296, 359, 348, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
185, 2arrA, 0.8632, 2.44, 0.311, 358, 351, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH
186, 3dlwA, 0.8628, 2.29, 0.461, 360, 345, ANTICHYMOTRYPSIN
187, 4ic0B, 0.8627, 2.32, 0.299, 358, 348, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
188, 4g8rA, 0.8621, 2.32, 0.302, 357, 348, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
189, 4robB, 0.8616, 2.58, 0.214, 356, 350, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
190, 4rsqK, 0.8610, 2.56, 0.209, 356, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
191, 2behL, 0.8608, 2.31, 0.308, 403, 347, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
192, 4rsqL, 0.8605, 2.57, 0.209, 356, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
193, 2b4xL, 0.8604, 2.37, 0.307, 410, 348, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
194, 2antL, 0.8595, 2.39, 0.307, 398, 348, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
195, 3evjL, 0.8594, 2.39, 0.305, 417, 348, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
196, 1r1lL, 0.8593, 2.39, 0.307, 409, 348, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
197, 4rsqG, 0.8589, 2.73, 0.211, 357, 351, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
198, 1e05L, 0.8589, 2.39, 0.307, 417, 348, PLASMA ALPHA ANTITHROMBIN-III
199, 1e04L, 0.8589, 2.34, 0.308, 412, 347, PLASMA BETA ANTITHROMBIN-III
200, 4rsqB, 0.8588, 2.59, 0.210, 355, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
201, 1jvqL, 0.8587, 2.40, 0.307, 406, 348, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
202, 1lk6L, 0.8586, 2.40, 0.305, 406, 348, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
203, 4rsqE, 0.8584, 2.61, 0.209, 356, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
204, 4rsqH, 0.8583, 2.80, 0.211, 357, 351, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
205, 1br8L, 0.8583, 2.42, 0.307, 398, 348, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
206, 2hijL, 0.8582, 2.36, 0.305, 409, 347, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
207, 1jrrA, 0.8579, 2.44, 0.309, 357, 349, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP
208, 4rsqI, 0.8578, 2.71, 0.212, 356, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
209, 4rsqF, 0.8577, 2.50, 0.210, 353, 347, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
210, 3zhaD, 0.8577, 2.76, 0.285, 368, 358, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
211, 1iz2A, 0.8574, 2.53, 0.974, 371, 350, INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING
212, 1dzhL, 0.8574, 2.37, 0.308, 407, 347, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
213, 4rsqJ, 0.8568, 2.65, 0.206, 355, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
214, 4robA, 0.8568, 2.63, 0.215, 356, 349, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
215, 1oyhL, 0.8568, 2.38, 0.308, 410, 347, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
216, 1e03L, 0.8566, 2.43, 0.305, 423, 348, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
217, 4rsqD, 0.8565, 2.74, 0.209, 355, 350, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
218, 1nq9L, 0.8564, 2.34, 0.309, 413, 346, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
219, 1dzgL, 0.8564, 2.39, 0.308, 409, 347, N135Q-S380C-ANTITHROMBIN-III
220, 1azxL, 0.8564, 2.43, 0.302, 414, 348, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
221, 4rsqA, 0.8563, 2.65, 0.210, 356, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
222, 1antL, 0.8562, 2.37, 0.308, 392, 347, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
223, 4rsqC, 0.8553, 2.76, 0.209, 354, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
224, 1a7cA, 0.8543, 2.52, 0.302, 364, 351, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE
225, 1wz9A, 0.8535, 2.27, 0.256, 357, 344, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
226, 1qmnA, 0.8528, 2.59, 0.458, 365, 347, ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION)
227, 4eb1L, 0.8526, 2.38, 0.310, 392, 345, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
228, 3zhaA, 0.8515, 2.88, 0.284, 380, 359, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
229, 3zhaB, 0.8514, 2.70, 0.291, 364, 354, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
230, 3zhaC, 0.8510, 2.93, 0.283, 376, 360, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
231, 4robC, 0.8497, 2.57, 0.214, 351, 345, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
232, 4ro9A, 0.8490, 2.60, 0.214, 353, 346, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
233, 5c98B, 0.8482, 2.81, 0.187, 364, 353, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
234, 3f5nE, 0.8476, 2.05, 0.298, 340, 336, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
235, 5cdzA, 0.8455, 2.33, 0.612, 361, 340, CRYSTAL STRUCTURE OF CONSERPIN IN THE LATENT STATE
236, 3cvmA, 0.8455, 2.58, 0.298, 377, 349, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
237, 4au4C, 0.8448, 2.94, 0.288, 370, 358, CRYSTAL STRUCTURE OF HSP47
238, 5c98A, 0.8447, 2.56, 0.191, 359, 346, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
239, 4ro9B, 0.8445, 2.51, 0.216, 348, 342, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
240, 3cvmB, 0.8445, 2.59, 0.298, 377, 349, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
241, 2v95A, 0.8435, 2.25, 0.413, 342, 339, STRUCTURE OF CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH CORTISOL
242, 1sngA, 0.8435, 2.23, 0.236, 349, 335, STRUCTURE OF A THERMOPHILIC SERPIN IN THE NATIVE STATE
243, 3zhaP, 0.8433, 2.99, 0.284, 373, 359, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
244, 4p0fA, 0.8416, 2.35, 0.308, 369, 341, CLEAVED SERPIN 42DA (C 2 2 21)
245, 3zhaQ, 0.8411, 2.92, 0.289, 365, 356, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
246, 3zhaL, 0.8406, 2.96, 0.286, 369, 357, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
247, 3eoxA, 0.8401, 2.55, 0.298, 370, 346, HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB
248, 3zhaK, 0.8391, 3.05, 0.284, 374, 359, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
249, 4au4G, 0.8388, 2.98, 0.287, 368, 356, CRYSTAL STRUCTURE OF HSP47
250, 4au4F, 0.8383, 2.97, 0.287, 368, 356, CRYSTAL STRUCTURE OF HSP47
251, 2wy0C, 0.8374, 2.91, 0.199, 424, 351, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM WITH SPACE GROUP P6122
252, 2wxyC, 0.8369, 2.92, 0.199, 419, 351, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE REDUCED FORM
253, 4au2A, 0.8360, 2.95, 0.290, 367, 355, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
254, 4au4E, 0.8351, 3.00, 0.290, 367, 355, CRYSTAL STRUCTURE OF HSP47
255, 4au4D, 0.8341, 2.98, 0.291, 366, 354, CRYSTAL STRUCTURE OF HSP47
256, 4au2D, 0.8328, 2.78, 0.290, 359, 348, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
257, 4au3D, 0.8319, 2.87, 0.283, 359, 350, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
258, 1athB, 0.8303, 2.24, 0.317, 362, 334, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
259, 4au4B, 0.8294, 3.10, 0.287, 368, 356, CRYSTAL STRUCTURE OF HSP47
260, 4au4A, 0.8290, 3.04, 0.288, 366, 354, CRYSTAL STRUCTURE OF HSP47
261, 4au2B, 0.8285, 2.77, 0.292, 354, 346, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
262, 4yiaA, 0.8284, 1.98, 0.437, 337, 325, STRUCTURAL MECHANISM OF HORMONE RELEASE IN THYROXINE BINDING GLOBULIN
263, 2xn6A, 0.8273, 1.99, 0.437, 337, 325, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN
264, 3stoA, 0.8267, 2.87, 0.235, 361, 344, SERPIN FROM THE TREMATODE SCHISTOSOMA HAEMATOBIUM
265, 2riwA, 0.8264, 2.01, 0.437, 337, 325, THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE
266, 2xn3A, 0.8260, 2.01, 0.437, 337, 325, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID
267, 2xn5A, 0.8258, 2.01, 0.437, 341, 325, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE
268, 2xn7A, 0.8254, 2.02, 0.437, 339, 325, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF)
269, 4aqhA, 0.8249, 2.79, 0.302, 382, 344, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
270, 2rivA, 0.8243, 2.04, 0.437, 339, 325, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN
271, 8apiA, 0.8229, 2.06, 0.991, 340, 325, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
272, 9apiA, 0.8220, 2.07, 0.991, 339, 325, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
273, 3nddA, 0.8220, 2.09, 0.988, 335, 325, CLEAVED ANTITRYPSIN WITH P10 PRO AND P9-P6 ASP
274, 4aqhC, 0.8219, 2.82, 0.302, 382, 344, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
275, 5m3yA, 0.8216, 3.11, 0.211, 418, 350, CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED ANGIOTENSINOGEN
276, 4aqhB, 0.8215, 2.82, 0.305, 383, 344, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
277, 7apiA, 0.8210, 2.08, 0.991, 339, 325, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
278, 4ro9C, 0.8207, 2.39, 0.221, 336, 330, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
279, 4r9iA, 0.8202, 3.05, 0.172, 378, 348, CRYSTAL STRUCTURE OF CYSTEINE PROTEINASE INHIBITOR SERPIN18 FROM BOMBYX MORI
280, 2wxzA, 0.8202, 3.33, 0.213, 422, 356, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
281, 2wxxC, 0.8197, 3.17, 0.205, 422, 351, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
282, 2wxwA, 0.8196, 3.12, 0.209, 438, 350, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN
283, 2d26A, 0.8194, 2.13, 0.972, 336, 325, ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX
284, 1d5sA, 0.8193, 2.12, 0.991, 334, 325, CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER
285, 1ezxA, 0.8189, 2.13, 0.991, 335, 325, CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
286, 3t1pA, 0.8186, 2.14, 0.982, 371, 325, CRYSTAL STRUCTURE OF AN ALPHA-1-ANTITRYPSIN TRIMER
287, 3ndfA, 0.8183, 2.14, 0.988, 336, 325, CLEAVED ANTITRYPSIN WITH P8-P6 ASP
288, 2x0bH, 0.8180, 3.11, 0.211, 423, 350, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
289, 2x0bF, 0.8180, 3.11, 0.211, 423, 350, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
290, 2x0bD, 0.8180, 3.11, 0.211, 423, 350, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
291, 2x0bB, 0.8180, 3.11, 0.211, 423, 350, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
292, 4au3B, 0.8165, 2.81, 0.283, 351, 343, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
293, 2wxxD, 0.8157, 3.15, 0.200, 411, 350, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
294, 2wxxB, 0.8156, 3.14, 0.202, 428, 351, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
295, 1as4A, 0.8148, 2.16, 0.478, 336, 324, CLEAVED ANTICHYMOTRYPSIN A349R
296, 2achA, 0.8141, 2.21, 0.477, 337, 325, CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS
297, 3lw2A, 0.8140, 2.64, 0.289, 365, 336, MOUSE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
298, 2wxxA, 0.8138, 3.18, 0.203, 412, 350, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
299, 5om7A, 0.8133, 2.25, 0.480, 338, 325, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II: A DRUG- BINDING SERPIN FOR DOXORUBICIN 
300, 5om6A, 0.8123, 2.24, 0.474, 339, 325, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
301, 4au3C, 0.8119, 3.13, 0.284, 357, 349, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
302, 5om2A, 0.8111, 2.29, 0.474, 338, 325, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I1: A DRUG- BINDING SERPIN FOR DOXYCYCLINE 
303, 4au3A, 0.8101, 3.03, 0.280, 354, 346, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
304, 1qmbA, 0.8091, 2.17, 0.988, 326, 322, CLEAVED ALPHA-1-ANTITRYPSIN POLYMER
305, 2pefA, 0.8083, 2.80, 0.249, 366, 337, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE LATENT STATE
306, 1c5gA, 0.8071, 3.11, 0.302, 379, 344, PLASMINOGEN ACTIVATOR INHIBITOR-1
307, 5om3A, 0.8067, 2.16, 0.477, 335, 321, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I5: A MMP14- CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
308, 4kdsA, 0.8065, 2.97, 0.268, 370, 339, CRYSTAL STRUCTURE OF LATENT RAINBOW TROUT PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1)
309, 5om5A, 0.8054, 2.32, 0.472, 338, 324, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO1: AN ALLOSTERICALLY TRIGGERED DRUG-BINDING SERPIN FOR DOXYCYCLINE 
310, 2wxzC, 0.8051, 3.23, 0.222, 413, 347, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
311, 2oayA, 0.8050, 2.58, 0.274, 368, 329, CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR
312, 3caaA, 0.8046, 2.20, 0.477, 334, 321, CLEAVED ANTICHYMOTRYPSIN A347R
313, 6ftpA, 0.8045, 2.31, 0.483, 335, 323, CRYSTAL FORM 1 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
314, 5om8A, 0.8040, 2.30, 0.477, 336, 323, CRYSTAL FORM 2 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
315, 4caaA, 0.8033, 2.21, 0.480, 333, 321, CLEAVED ANTICHYMOTRYPSIN T345R
316, 2wy1B, 0.8032, 3.27, 0.213, 417, 348, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
317, 2wy1A, 0.8032, 3.27, 0.213, 418, 348, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
318, 4bb2A, 0.8030, 2.21, 0.447, 332, 320, CRYSTAL STRUCTURE OF CLEAVED CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH PROGESTERONE
319, 4afxA, 0.8007, 2.40, 0.322, 347, 323, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN I2 SPACE GROUP
320, 5om6C, 0.7996, 2.37, 0.477, 335, 323, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
321, 1dvnA, 0.7996, 3.17, 0.303, 379, 343, LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
322, 2h4pA, 0.7966, 2.62, 0.317, 350, 325, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE CLEAVED CONFORMATION
323, 4au2C, 0.7961, 2.61, 0.295, 338, 329, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
324, 1lj5A, 0.7960, 3.32, 0.302, 379, 344, 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1)
325, 4ajuA, 0.7952, 2.50, 0.326, 349, 322, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN P41 SPACE GROUP
326, 1hleA, 0.7944, 2.38, 0.330, 344, 321, CRYSTAL STRUCTURE OF CLEAVED EQUINE LEUCOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95 ANGSTROMS RESOLUTION
327, 2h4qA, 0.7936, 2.39, 0.324, 352, 321, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE CLEAVED CONFORMATION
328, 2vh4A, 0.7912, 2.96, 0.248, 380, 335, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
329, 1lq8A, 0.7911, 2.34, 0.475, 329, 318, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
330, 1lq8G, 0.7900, 2.41, 0.475, 330, 318, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
331, 1lq8C, 0.7894, 2.31, 0.476, 328, 317, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
332, 3dy0A, 0.7893, 2.35, 0.487, 327, 318, CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN
333, 1lq8E, 0.7891, 2.42, 0.486, 329, 319, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
334, 5ncwA, 0.7858, 2.44, 0.245, 334, 319, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN (V367K/K368A MUTANT).
335, 5m3xB, 0.7811, 3.22, 0.217, 387, 337, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
336, 2vh4B, 0.7806, 2.84, 0.247, 374, 328, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
337, 5inwA, 0.7781, 2.47, 0.319, 335, 317, STRUCTURE OF REACTION LOOP CLEAVED LAMPREY ANGIOTENSINOGEN
338, 5m3xA, 0.7770, 3.23, 0.220, 383, 336, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
339, 5ncuA, 0.7755, 2.50, 0.247, 329, 316, STRUCTURE OF THE SUBTILISIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
340, 5inwB, 0.7742, 2.46, 0.321, 331, 315, STRUCTURE OF REACTION LOOP CLEAVED LAMPREY ANGIOTENSINOGEN
341, 5nctA, 0.7713, 2.44, 0.249, 325, 313, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
342, 2znhB, 0.7710, 2.22, 0.301, 412, 309, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
343, 3f02B, 0.7674, 2.32, 0.288, 327, 309, CLEAVED HUMAN NEUROSERPIN
344, 2znhA, 0.7664, 2.20, 0.300, 408, 307, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
345, 9paiA, 0.7608, 2.97, 0.295, 346, 322, CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1
346, 3f02A, 0.7559, 2.35, 0.289, 322, 305, CLEAVED HUMAN NEUROSERPIN
347, 1mtpA, 0.7483, 2.72, 0.248, 320, 307, THE X-RAY CRYSTAL STRUCTURE OF A SERPIN FROM A THERMOPHILIC PROKARYOTE
348, 1c8oA, 0.7051, 2.60, 0.266, 300, 289, 2.9 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
349, 1f0cA, 0.6830, 2.58, 0.274, 297, 281, STRUCTURE OF THE VIRAL SERPIN CRMA
350, 1m93B, 0.5601, 2.55, 0.284, 245, 232, 1.65 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
351, 1jjoD, 0.5533, 2.52, 0.302, 244, 225, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
352, 1jjoC, 0.5533, 2.52, 0.302, 244, 225, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
